InspireMD (NYSE:NSPR) said today it is postponing a stockholder meeting in which the company was taking into consideration a reverse stock split. The Israel-based company had originally planned to meet yesterday, but has moved the date back to Oct. 27 as it considers either a 1-for-10 or 1-for-25 reverse split of its stock. If approved, the […]
InspireMD
7 medtech stories we missed this week: Aug. 25, 2017
From InspireMD’s Swiss distribution deal to CoreLink’s stackable guide wire launch, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD announces Swiss distribution deal InspireMD announced in an Aug. 25 press release that it has signed an agreement with 1a Medical to distribute the CGuard EPS […]
7 medtech stories we missed this week: June 9, 2017
From 3M’s expanded 510(k) clearance for its Tegaderm dressing to Medtronic and Acacia burying the hatchet, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks Taiwanese distro deal for CGuard InspireMD announced in a June 8 press release that it has signed a distribution deal with […]
InspireMD inks German CGuard EPS distribution deal
InspireMD (NYSE:NSPR) said today it inked a German distribution deal with AB medica Deutschland GmbH. Through the deal, AB medica will gain the rights to distribute the company’s CGuard EPS embolic prevention system in the region, the Israel-based company said. “AB medica GmbH is probably the leading distributor in the peripheral and vascular medical devices sector in […]
InspireMD prices upcoming $7.5m offering
InspireMD (NYSE:NSPR) today priced an upcoming offering, looking to raise $7.5 million to expand sales and marketing of its CGuard and MGuard Prime embolic prevention systems. In the round, the Israel-based company will float up to 1.2 million shares of Series C convertible preferred stock, Series B warrants to purchase up to 4.7 million shares of common […]
InspireMD logs provisional win in $3m funding fee bid
InspireMD (NYSE:NSPR) logged a provisional win yesterday in a battle over nearly $3 million it allegedly owes in finder’s fees related to some $24 million in financing for the cardiac device maker. Private equity shop Microbanc and managing member Todd Spenla sued InspireMD in May 2016, alleging that the company breached a contract stipulating a 9% finder’s […]
InspireMD registers for $25m Series C
InspireMD (NYSE:NSPR) this week registered for a $24.8 million Series C round, with funding slated to support sales and new product development. The Boston-based company will offer 1.1 million shares of Series C convertible preferred stock and warrants to purchase an additional 4.6 million shares of common stock. Each share of preferred stock to be offered in […]
InspireMD pulls trigger on 1-for-25 reverse split
InspireMD (NYSE:NSPR) said yesterday it initiated a 1-for-25 reverse split of its stock, effective Oct. 7, with its stock trading on a split adjusted basis starting Oct. 10. The move will reduce the shares of InspireMD on the market by putting 1 share of common stock in the hands of shareholders for every 25 shares they held […]
InspireMD closes $15m offering
InspireMD (NYSE:NSPR) said yesterday that it raised $14.6 million in a “best efforts” stock offering it plans to use to boost sales of its anti-stroke devices. Boston-based InspireMD said the offering consisted of 442,424 shares of Series B stock convertible into 100 shares of common stock at 33¢ per share, with a 5-year cumulative dividend rate of 15% a […]
InspireMD prices $15m offering
InspireMD (OTC:NSPR) this week priced a new public offering, looking to bring in approximately $15 million through the sale of 442,424 shares of Series B convertible preferred stock and accompanying warrants to purchase approximately 44.2 million shares of common stock. Each share of Series B convertible preferred stock being offered in the round is convertible to […]
InspireMD lifts COO Barry to the corner office | Personnel Moves June 8, 2016
InspireMD lifts COO Barry to the corner office InspireMD (OTC:NSPR) said yesterday it promoted COO Dr. James Barry to the office of CEO and president, effectively immediately. Former CEO Alan Milinazzo announced he would step down from the position in January. “We are extremely pleased to name Dr. Barry as President and CEO. Jim brings an […]